Inactive Instrument

News Pfizer Inc Nyse

Equities

End-of-day quote Nyse Other stock markets
- ^USD	-

May. 03	GSK plc : Back on track
May. 03	Wall Street: optimism ahead of NFP, rates ease	CF

GSK Sues Pfizer, Pharmacia & Upjohn & BioNTech For Infringing MRNA Vaccine Patents	May. 03	AQ
NICE recommends new haemolytic anaemia treatment	May. 03	AQ
AM Best Affirms Credit Ratings of Blue Whale Re Ltd	May. 03	AQ
GSK plc : Back on track	May. 03
Wall Street: optimism ahead of NFP, rates ease	May. 02	CF
PFIZER INC : Buy rating from DZ Bank	May. 02	ZD
Morgan Stanley Adjusts Price Target on Pfizer to $29 From $28	May. 02	MT
Leerink Adjusts Price Target on Pfizer to $29 From $27	May. 02	MT
BMO Capital Adjusts Pfizer's Price Target to $36 From $33, Keeps Outperform Rating	May. 02	MT
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Prepared Remarks	May. 02	PU
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Infographic	May. 02	PU
Moderna quarterly sales beat expectations but plummet from previous year	May. 02	RE
Morgan Stanley Lifts Price Target on Pfizer to $29 From $28, Keeps Equalweight Rating	May. 02	MT
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Press Release	May. 02	PU
Pfizer : April Social Media Round-Up—Black Maternal Health, World Immunization, and Long Covid	May. 02	PU
Health Care Climbs as Pfizer, GSK Rise -- Health Care Roundup	May. 01	DJ
US Equity Markets Close Mixed Wednesday After Fed Holds Rates Steady	May. 01	MT
Sector Update: Health Care Stocks Rise Late Afternoon	May. 01	MT
PFIZER INC : Jefferies gives a Buy rating	May. 01	ZD
Trending : Pfizer 1Q Earnings Top Estimates; Raises FY24 View	May. 01	DJ

No results for this search

Pfizer, Inc: A cycle for nothing?

December 14, 2023 at 10:58 am EST

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs